tiprankstipranks
Trending News
More News >
MustGrow Biologics (MGROF)
OTHER OTC:MGROF
US Market
Advertisement

MustGrow Biologics (MGROF) Ratios

Compare
11 Followers

MustGrow Biologics Ratios

MGROF's free cash flow for Q1 2025 was C$0.14. For the 2025 fiscal year, MGROF's free cash flow was decreased by C$ and operating cash flow was C$-0.42. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.68 5.72 4.63 11.24 9.62
Quick Ratio
1.04 5.72 4.63 11.24 9.62
Cash Ratio
0.54 5.62 4.56 11.15 9.45
Solvency Ratio
-0.86 -0.50 -2.94 -2.31 -3.01
Operating Cash Flow Ratio
-1.66 -0.24 -2.11 -2.79 -7.36
Short-Term Operating Cash Flow Coverage
-11.96 -0.48 -8.06 -6.57 -12.53
Net Current Asset Value
C$ -148.34KC$ 5.58MC$ 5.24MC$ 8.46MC$ 2.32M
Leverage Ratios
Debt-to-Assets Ratio
0.45 0.11 0.11 0.08 0.27
Debt-to-Equity Ratio
4.82 0.14 0.14 0.09 0.39
Debt-to-Capital Ratio
0.83 0.12 0.13 0.08 0.28
Long-Term Debt-to-Capital Ratio
0.80 0.02 0.06 0.04 0.23
Financial Leverage Ratio
10.83 1.24 1.36 1.15 1.45
Debt Service Coverage Ratio
-9.94 -1.09 -13.35 -7.30 -13.16
Interest Coverage Ratio
-127.59 0.00 -551.93 -57.07 -73.45
Debt to Market Cap
0.08 0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
0.06 0.02 0.02 0.02 0.03
Net Debt to EBITDA
-0.20 8.95 1.13 2.95 0.74
Profitability Margins
Gross Profit Margin
18.75%91.84%100.00%100.00%0.00%
EBIT Margin
-132.97%-14.37%-85750.50%-23398.17%0.00%
EBITDA Margin
-133.42%-14.37%-85750.52%-23398.17%0.00%
Operating Profit Margin
-130.75%-17.08%-85750.50%-23398.17%0.00%
Pretax Profit Margin
-131.46%-14.37%-85905.87%-23808.18%0.00%
Net Profit Margin
-131.46%-14.37%-85507.64%-24218.20%0.00%
Continuous Operations Profit Margin
-131.46%-14.37%-85905.87%-23808.18%0.00%
Net Income Per EBT
100.00%100.00%99.54%101.72%101.39%
EBT Per EBIT
100.54%84.09%100.18%101.75%98.24%
Return on Assets (ROA)
-77.76%-9.76%-77.65%-32.12%-99.52%
Return on Equity (ROE)
-221.14%-12.12%-105.75%-36.85%-144.34%
Return on Capital Employed (ROCE)
-163.64%-14.06%-99.31%-34.07%-111.51%
Return on Invested Capital (ROIC)
-141.16%-12.69%-92.19%-33.27%-105.85%
Return on Tangible Assets
-84.65%-9.76%-77.65%-32.12%-99.52%
Earnings Yield
-13.30%-1.05%-3.19%-2.00%-2.53%
Efficiency Ratios
Receivables Turnover
3.08 49.70 0.07 0.20 0.00
Payables Turnover
1.06 1.36 0.00 0.00 0.00
Inventory Turnover
1.42 0.00 0.00 0.00 0.00
Fixed Asset Turnover
18.54 0.00 0.00 0.00 0.00
Asset Turnover
0.59 0.68 <0.01 <0.01 0.00
Working Capital Turnover Ratio
1.94 0.83 <0.01 <0.01 0.00
Cash Conversion Cycle
32.16 -261.93 4.95K 1.82K 0.00
Days of Sales Outstanding
118.54 7.34 4.95K 1.82K 0.00
Days of Inventory Outstanding
257.02 0.00 0.00 0.00 0.00
Days of Payables Outstanding
343.40 269.27 0.00 0.00 0.00
Operating Cycle
375.56 7.34 4.95K 1.82K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-0.12 >-0.01 -0.07 -0.06 -0.07
Free Cash Flow Per Share
-0.12 >-0.01 -0.07 -0.06 -0.07
CapEx Per Share
<0.01 <0.01 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-572.89 -73.69K 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
-572.89 -73.69K 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
-1.97 -0.39 -4.29 -3.22 -2.86
Operating Cash Flow to Sales Ratio
-1.48 -0.06 -502.78 -187.41 0.00
Free Cash Flow Yield
-15.02%-0.46%-1.88%-1.55%-1.94%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-7.52 -95.08 -31.32 -49.96 -39.58
Price-to-Sales (P/S) Ratio
9.88 13.66 26.78K 12.10K 0.00
Price-to-Book (P/B) Ratio
63.30 11.53 33.12 18.41 57.13
Price-to-Free Cash Flow (P/FCF) Ratio
-6.66 -218.36 -53.26 -64.56 -51.51
Price-to-Operating Cash Flow Ratio
-6.67 -218.36 -53.26 -64.56 -51.51
Price-to-Earnings Growth (PEG) Ratio
0.47 1.08 -0.58 2.41 -0.87
Price-to-Fair Value
63.30 11.53 33.12 18.41 57.13
Enterprise Value Multiple
-7.61 -86.13 -30.10 -48.76 -39.96
Enterprise Value
42.44M 58.31M 167.24M 146.83M 130.42M
EV to EBITDA
-7.61 -86.13 -30.10 -48.76 -39.96
EV to Sales
10.15 12.37 25.81K 11.41K 0.00
EV to Free Cash Flow
-6.84 -197.81 -51.34 -60.88 -50.57
EV to Operating Cash Flow
-6.85 -197.81 -51.34 -60.88 -50.57
Tangible Book Value Per Share
<0.01 0.11 0.11 0.19 0.06
Shareholders’ Equity Per Share
0.01 0.11 0.11 0.19 0.06
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 <0.01 -0.02 -0.01
Revenue Per Share
0.08 0.09 <0.01 <0.01 0.00
Net Income Per Share
-0.11 -0.01 -0.11 -0.07 -0.09
Tax Burden
1.00 1.00 1.00 1.02 1.01
Interest Burden
0.99 1.00 1.00 1.02 1.01
Research & Development to Revenue
0.14 0.18 73.45 35.62 0.00
SG&A to Revenue
0.88 0.66 697.47 155.23 0.00
Stock-Based Compensation to Revenue
0.33 0.29 261.54 21.04 0.00
Income Quality
1.13 0.44 0.59 0.79 0.78
Currency in CAD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis